AACR Grant Giving
Investing in Innovation: The AACR grants program sparks innovation in basic, translational, and clinical research by providing critical support to promising investigators at all career levels.
Learn More
Investing in Innovation: The AACR grants program sparks innovation in basic, translational, and clinical research by providing critical support to promising investigators at all career levels.
Learn More
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreIn the latest episode of Believe in Progress, a podcast of the AACR Foundation, Mitch Stoller talks with Kristen Dahlgren, a former NBC journalist, breast cancer survivor, and dedicated advocate for cancer research.
Listen and SubscribeMore than 41,500 people a year in the U.S. are diagnosed with liver cancer. It’s Liver Cancer Awareness Month. Read about the prevention, screening, and treatment options for this type of cancer.
Learn MoreDoes structural racism affect cancer health disparities? Structural racism and its impact on the biology of cancer was a key topic at the recent AACR Conference on the Science of Cancer Health Disparities.
Read the AACR BlogStudy: Immunotherapy may make surgery an option for patients with early-stage liver cancer who would be considered ineligible under traditional rules.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSubmit an abstract for the AACR Annual Meeting 2025 (April 25-30, Chicago).
Deadline: November 26
The AACR Cancer Progress Report 2024 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. LoRusso, AACR President 2024-2025, explains that basic cancer research is essential to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2021
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2023, to June 30, 2024
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
